IVD Infectious Diseases Market to Surpass USD 31.45 Billion by 2026
Growing prevalence of target diseases, health awareness, and high demand for self-care medical devices are estimated to accentuate market growth over the forecast period.
(firmenpresse) - The global in-vitro diagnostics infectious diseases market size is likely to reach USD 31.45 billion by 2026, according to a new report by Grand View Research, Inc., experiencing a CAGR of 6.7% during the forecast period. Increasing geriatric population and rising consumer awareness regarding the merits of IVD tests are expected to drive the IVD infectious diseases market.
Growing prevalence of target diseases, health awareness, and high demand for self-care medical devices are estimated to accentuate market growth over the forecast period. Moreover, introduction of technologically advanced products with improved sensitivity, speed, and user-friendliness are anticipated to increase the adoption of in-vitro diagnostics for infectious diseases in the next few years.
Key IVD techniques include immunochemistry assays, such as Enzyme-linked Immunosorbent Assay (ELISA) and Immuno-agglutination. These are widely used in clinical laboratories and diagnostic centers for detecting infectious microorganisms such as bacteria and virus in patient samples.
North America dominated the market, supported by presence of sophisticated healthcare infrastructure, government initiatives pertaining to research & development activities, and high awareness levels of patients and practitioners. The Asia Pacific IVD infectious diseases market is projected to witness the fastest growth over the forecast period.
Access Research Report of IVD Infectious Diseases Market (at) https://www.grandviewresearch.com/industry-analysis/ivd-infectious-disease-market
Further key findings from the report suggest:
Introduction of technologies such as qPCR and ELISA has enhanced usage rates of IVD products for infectious disease testing
High unmet consumer needs, supported by rising disposable income and awareness levels in emerging markets, is a key growth stimulant
Immunochemistry assays, such as ELISA and chemiluminescence immunoassays, are projected to be widely used over the forecast period
Molecular diagnostics is poised to witness strong growth, driven by wide adoption and improved accuracy levels
Key players in the market include Becton Dickinson; bioMerieux; Abbott Laboratories; Quidel Corporation; Alere Inc.; Orasure Technologies, Inc.; Hologic Inc.; Cepheid; Qiagen N.V.; Roche Diagnostics; Siemens Healthcare; and Bio-Rad Laboratories, Inc.
Grand View Research has segmented the global IVD infectious diseases market based on product, technology, application, end use, and region:
Product Outlook (Revenue, USD Million, 2014 - 2026)
Instruments
Reagents
Software
Technology Outlook (Revenue, USD Million, 2014 - 2026)
Immunochemistry
Molecular Diagnostics
Microbiology
Others
Application Outlook (Revenue, USD Million, 2014 - 2026)
MRSA
Streptococcus
Clostridium difficile
VRE
CRE
Respiratory Virus
Candida
TB and Drug-resistant TB
Gastro-intestinal Panel Testing
Chlamydia
Gonorrhea
HPV
HIV
Hepatitis C
Hepatitis B
Others
End-use Outlook (Revenue, USD Million, 2014 - 2026)
Point of Care
Central Laboratories
Regional Outlook (Revenue, USD Million, 2014 - 2026)
North America
US.
Canada
Europe
UK.
Germany
Spain
France
Italy
Latin America
Brazil
Mexico
Argentina
Asia Pacific
Japan
China
India
South Korea
Australia
Middle East & Africa
South Africa
Saudi Arabia
A.E.
Access Press Release of IVD Infectious Diseases Market(at) https://www.grandviewresearch.com/press-release/global-ivd-infectious-disease-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.
For More Information: www.grandviewresearch.com
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 12.11.2019 - 11:30 Uhr
Sprache: Deutsch
News-ID 602030
Anzahl Zeichen: 4782
contact information:
Contact person: Sonali Kulkarni
Town:
San Francisco
Phone: 14153490058
Kategorie:
Healthcare & Medical
Typ of Press Release: please
type of sending: don't
Diese Pressemitteilung wurde bisher 187 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"IVD Infectious Diseases Market to Surpass USD 31.45 Billion by 2026"
steht unter der journalistisch-redaktionellen Verantwortung von
Grand View Research Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
